CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 113 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -21.1% | 4,501 | +0.6% | 0.00% | – |
| Q2 2021 | $19,000 | -9.5% | 4,472 | +8.5% | 0.00% | – |
| Q1 2021 | $21,000 | +23.5% | 4,123 | +191.4% | 0.00% | – |
| Q1 2019 | $17,000 | -43.3% | 1,415 | -41.5% | 0.00% | – |
| Q4 2018 | $30,000 | -16.7% | 2,419 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | -12.2% | 2,419 | 0.0% | 0.00% | – |
| Q2 2018 | $41,000 | -25.5% | 2,419 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -62.6% | 2,419 | -57.3% | 0.00% | -100.0% |
| Q4 2017 | $147,000 | +110.0% | 5,668 | +19.9% | 0.00% | 0.0% |
| Q3 2017 | $70,000 | +6.1% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $66,000 | -18.5% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $81,000 | +65.3% | 4,728 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $49,000 | – | 4,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |